Crawford Valuation
Is CRD.B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CRD.B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CRD.B ($10.77) is trading below our estimate of fair value ($11.24)
Significantly Below Fair Value: CRD.B is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRD.B?
Key metric: As CRD.B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is CRD.B's PE Ratio? | |
|---|---|
| PE Ratio | 26.3x |
| Earnings | US$20.06m |
| Market Cap | US$555.65m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | 13.3x |
| PEG Ratio | 0.4x |
Price to Earnings Ratio vs Peers
How does CRD.B's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 34.9x | ||
WDH Waterdrop | 11.6x | 17.8% | US$420.6m |
TWFG TWFG | 76x | 43.3% | US$1.8b |
ZBAO Zhibao Technology | 48.6x | n/a | US$97.1m |
AIFU AIX | 3.5x | n/a | US$67.5m |
CRD.B Crawford | 26.3x | 61.1% | US$555.6m |
Price-To-Earnings vs Peers: CRD.B is good value based on its Price-To-Earnings Ratio (26.3x) compared to the peer average (34.9x).
Price to Earnings Ratio vs Industry
How does CRD.B's PE Ratio compare vs other companies in the US Insurance Industry?
Price-To-Earnings vs Industry: CRD.B is expensive based on its Price-To-Earnings Ratio (26.3x) compared to the US Insurance industry average (13.5x).
Price to Earnings Ratio vs Fair Ratio
What is CRD.B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 26.3x |
| Fair PE Ratio | 26.6x |
Price-To-Earnings vs Fair Ratio: CRD.B is good value based on its Price-To-Earnings Ratio (26.3x) compared to the estimated Fair Price-To-Earnings Ratio (26.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Fidelis Insurance Holdings
US$2.2b
A specialty insurer, provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom.
FIHL
US$19.90
7D
-0.2%
1Y
62.1%
Markel Group
US$21.5b
A diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany.
MKL
US$1,694.12
7D
2.3%
1Y
18.5%
China Life Insurance
HK$1.1t
Operates as a life insurance company in the People’s Republic of China.
CILJ.F
HK$2.00
7D
-0.6%
1Y
46.0%